Endocuff + GI Genius for Colon Cancer Detection
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if using two devices together can improve the detection of colon polyps during a colonoscopy. The Endocuff attaches to the colonoscope to help spot polyps, while the GI Genius uses computer technology to assist in finding them. The study compares the use of both devices simultaneously with the use of the GI Genius alone. It involves patients scheduled for a routine colonoscopy to check for colon issues. As an unphased trial, this study allows patients to contribute to research that could enhance the effectiveness of colonoscopies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude patients on continuous anti-thrombotic therapy. It's best to discuss your specific medications with the trial team.
What prior data suggests that the Endocuff and CADe system are safe for colonoscopy procedures?
Research shows that both Endocuff and GI Genius are safe and effective for finding polyps during colonoscopies. Studies have found that Endocuff, a device attached to the colonoscope, helps spot small growths. GI Genius, an artificial intelligence system, also improves the detection of adenomas, a type of polyp.
Previous research reports that patients tolerate both technologies well, with no major side effects during colonoscopies. This suggests that using Endocuff and GI Genius together is likely safe for participants, as each has demonstrated safety in earlier studies.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the Endocuff + GI Genius system for colon cancer detection because it offers a novel approach to identifying polyps. Unlike standard colonoscopies, which rely solely on a doctor's visual assessment, this system uses Endocuff, an attachment that improves the view of the colon, combined with GI Genius, an AI-powered computer-aided detection (CADe) system. This combination enhances the ability to spot polyps that might otherwise be missed. The integration of AI technology in GI Genius is particularly promising as it can potentially lead to earlier and more accurate detection of colon cancer, improving patient outcomes.
What evidence suggests that this trial's treatments could be effective for colon cancer detection?
This trial will compare the effectiveness of using Endocuff with the GI Genius system versus the GI Genius system alone for detecting small growths, called adenomas, and other problem areas in the colon. Research has shown that combining Endocuff with the GI Genius system greatly improves detection rates. One study found that the combination detected adenomas 60% of the time, compared to 37% with the GI Genius alone. This suggests that adding Endocuff helps spot polyps that might otherwise be missed. In short, strong evidence indicates that using both tools together is more effective at finding potential cancerous growths during colonoscopies.16789
Who Is on the Research Team?
Wesam Frandah, MD
Principal Investigator
Marshall University Joan C. Edwards School of Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are due for a routine outpatient colonoscopy to screen or monitor for colorectal cancer. It's not suitable for pregnant individuals, those with severe colitis, bowel obstructions, history of colon surgery, hereditary polyposis syndrome, untreated colon cancer or on continuous anti-thrombotic therapy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo colonoscopy procedures using either the Endocuff with CADe or CADe alone for colorectal cancer screening and surveillance
Follow-up
Participants are monitored for adenoma detection rate and safety after the colonoscopy procedure
What Are the Treatments Tested in This Trial?
Interventions
- CADe
- Endocuff
Find a Clinic Near You
Who Is Running the Clinical Trial?
Marshall University
Lead Sponsor